Characteristics | No. of cases (total: 79) | LINC01133 expression level | ABHD11-AS1 expression level | ||||
---|---|---|---|---|---|---|---|
Low N (%) | High N (%) | P-value | Low N (%) | High N (%) | P-value | ||
Age at diagnosis (2 missing, n = 77) | |||||||
≤ 40 | 20 | 9 (25.0%) | 11 (26.8%) | 0.86 | 7 (19.4%) | 13 (31.7%) | 0.22 |
> 40 | 57 | 27 (75.0%) | 30 (73.2%) | 29 (80.6%) | 28 (68.3%) | ||
Tumor size (1 missing, n = 78) | |||||||
< 2 cm | 23 | 11 (29.7%) | 12 (29.3%) | 0.93 | 9 (23.1%) | 14 (35.9%) | 0.43 |
2–5 cm | 41 | 20 (54.1%) | 21 (51.2%) | 23 (59.0%) 18 (46.2%) | |||
> 5 cm | 14 | 6 (16.2%) | 8 (19.5%) | 7 (17.9%) | 7 (17.9%) | ||
Tumor subtype (n = 79) | |||||||
Luminal A | 65 | 32 (80.0%) | 33 (84.6%) | 0.59 | 34 (81.0%) | 31 (83.8%) | 0.74 |
Luminal B | 14 | 8 (20.0%) | 6 (15.4%) | 8 (19.0%) | 6 (16.2%) | ||
Grade (n = 79) | |||||||
1 | 11 | 7 (18%) | 4 (10.0%) | 0.42 | 5 (12.2%) | 6 (15.8%) | 0.87 |
2 | 54 | 24 (61.5%) | 30 (75.0%) | 29 (70.7%) | 25 (65.8%) | ||
3 | 14 | 8 (20.5%) | 6 (15.0%) | 7 (17.1%) | 7 (18.4%) | ||
Stage (2 missing, n = 77) | |||||||
I | 6 | 2 (5.4%) | 4 (10.0%) | 0.62 | 1 (2.4%) | 5 (13.9%) | 0.16 |
II | 42 | 22 (59.4%) 20 (50.0%) | 23 (56.1%) | 19 (52.8%) | |||
III | 29 | 13 (35.2%) | 16 (40.0%) | 17 (41.5%) | 12 (33.3%) | ||
Pathology of tumors (7 missing, n = 72) | |||||||
DCIS | 3 | 2 (5.9%) | 1 (2.6%) | 0.80 | 1 (3.0%) | 2 (5.1%) | 0.85 |
LCIS | 3 | 1 (2.9%) | 2 (5.3%) | 1 (3.0%) | 2 (5.1%) | ||
IDC | 57 | 28 (82.4%) | 29 (76.3%) | 28 (85.0%) | 29 (74.4%) | ||
ILC | 4 | 1 (2.9%) | 3 (7.9%) | 1 (3.0%) | 3 (7.7%) | ||
Others | 5 | 2 (5.9%) | 3 (7.9%) | 2 (6.0%) | 3 (7.7%) | ||
Progesterone receptor (n = 79) | |||||||
Negative | 10 | 4 (10.5%) | 6 (14.6%) | 0.58 | 4 (9.8%) | 6 (15.8%) | 0.42 |
Positive | 69 | 34 (89.5%) | 35 (85.4%) | 37 (90.2%) | 32 (84.2%) | ||
Estrogen receptor (n = 79) | |||||||
Negative | 0 | 0 (0.0%) | 0 (0.0%) | – | 0 (0.0%) | 0 (0.0%) | – |
Positive | 79 | 38 (100.0%) 41 (100.0%) | 40 (100.0%) | 39 (100.0%) | |||
HER2 (n = 79) | |||||||
Negative | 70 | 32 (86.5%) | 38 (90.5%) | 0.58 | 37 (90.2%) | 33 (86.8%) | 0.63 |
Positive | 9 | 5 (13.5%) | 4 (9.5%) | 4 (9.8%) | 5 (13.2%) |